StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.35−0.14 (-9.40%)

Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –

Actinium Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Actinium Pharmaceuticals's EV/EBITDA was 1.4× on Nov 11, 2026.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.4×–

More Actinium Pharmaceuticals figures

See a number that looks wrong?